Eupraxia Pharmaceuticals (EPRX) Stock Chart & Stock Price History $5.30 -0.10 (-1.78%) Closing price 08/1/2025 03:50 PM EasternExtended Trading$5.58 +0.27 (+5.18%) As of 08/1/2025 05:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Eupraxia Pharmaceuticals Stock Price Performance The Eupraxia Pharmaceuticals (EPRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 106.38%, with a year-to-date return of 67.32%. In the past month, the stock has decreased 3.03%, reflecting recent market activity. As of the latest close, Eupraxia Pharmaceuticals traded at $5.30 with a market cap of $190.73 million and volume of 4,758 shares. Receive EPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-5.89%1 Month Performance-3.03%3 Month Performance+32.43%Year-To-Date Performance+67.32%1 Year Performance+106.38% EPRX Stock Chart for Saturday, August, 2, 2025 EPRX Chart by TradingView Eupraxia Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$5.40$5.30-1.78%$5.35$5.184,758 shs$190.73 million07/31/2025$5.29$5.40+2.08%$5.66$5.2016,029 shs$194.18 million07/30/2025$5.58$5.29-5.20%$5.56$5.2526,227 shs$190.23 million07/29/2025$5.64$5.58-0.99%$5.58$5.555,589 shs$200.64 million07/28/2025$5.49$5.64+2.66%$5.67$5.4724,864 shs$202.67 million07/25/2025$5.54$5.49-0.90%$5.60$5.3431,871 shs$197.42 million07/24/2025$5.14$5.54+7.70%$5.69$5.3026,534 shs$199.22 million07/23/2025$5.07$5.14+1.48%$5.14$5.012,239 shs$184.96 million07/22/2025$5.09$5.07-0.31%$5.13$4.884,743 shs$182.28 million07/21/2025$5.29$5.09-3.88%$5.26$5.106,869 shs$182.86 million Get the Latest News and Ratings for EPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$5.41$5.29-2.22%$5.38$5.264,195 shs$190.23 million07/17/2025$5.35$5.41+1.12%$5.47$5.303,484 shs$194.54 million07/16/2025$5.35$5.35+0.02%$5.60$5.3512,275 shs$192.37 million07/15/2025$5.59$5.35-4.31%$5.61$5.383,393 shs$192.35 million07/14/2025$5.44$5.59+2.78%$5.64$5.3122,873 shs$201.02 million07/11/2025$5.57$5.44-2.37%$5.54$5.365,792 shs$195.59 million07/10/2025$5.46$5.57+2.03%$5.68$5.493,595 shs$200.32 million07/09/2025$5.59$5.46-2.33%$5.66$5.4610,877 shs$196.34 million07/08/2025$5.54$5.59+0.92%$5.90$5.3910,733 shs$201.02 million07/07/2025$5.47$5.54+1.35%$5.67$5.396,820 shs$199.18 million07/04/2025$5.47$5.47$5.74$5.308,647 shs$196.52 million07/03/2025$5.47$5.47-0.09%$5.74$5.308,647 shs$196.51 million07/02/2025$5.84$5.47-6.34%$5.75$5.3912,256 shs$196.70 million07/01/2025$5.76$5.84+1.39%$6.20$5.8221,918 shs$210.01 million Related Companies Amylyx Pharmaceuticals Stock Chart Xencor Stock Chart Autolus Therapeutics Stock Chart atai Life Sciences Stock Chart Dianthus Therapeutics Stock Chart Day One Biopharmaceuticals Stock Chart Pharming Group Stock Chart Gyre Therapeutics Stock Chart MeiraGTx Stock Chart Prime Medicine Stock Chart Receive EPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EPRX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eupraxia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eupraxia Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
